FNYS
ARIA

First New York Securities’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

First New York Securities’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,000
Closed -$88K – 519
2013
Q4 		$88K Buy
+13,000
New +$70.2K 0.05% 161

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First New York Securities's ARIA Position: Q1 2014 in Review

First New York Securities sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2014, closing a stake of 13,000 shares — an estimated $88K sold.

First New York Securities first reported a position in ARIA in Q4 2013 and held it in 1 quarter. The position peaked at $88K in Q4 2013. 171 funds tracked by Wall St. Rank hold ARIA as of Q1 2014.

  • First New York Securities reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • First New York Securities sold 13,000 Ariad Pharmaceuticals Inc shares in Q1 2014, an estimated $88K.
  • First New York Securities first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 1 quarter.
  • First New York Securities's Ariad Pharmaceuticals Inc position peaked at $88K in Q4 2013.
  • 171 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2014.

Based on First New York Securities's 13F filing for Q1 2014, filed 15 May 2014.